Birgitte Volck's most recent trade in Soleno Therapeutics Inc was a trade of 3,991 Common Stock done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Soleno Therapeutics Inc | Birgitte Volck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 3,991 | 17,536 (0%) | 0% | 0 | Common Stock | |
| Soleno Therapeutics Inc | Birgitte Volck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 6,500 | 13,545 (0%) | 0% | 0 | Common Stock | |
| Soleno Therapeutics Inc | Birgitte Volck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 10,000 | 10,000 | - | - | Stock option (right to buy) | |
| Soleno Therapeutics Inc | Birgitte Volck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 2,666 | 2,666 | - | - | Stock option (right to buy) | |
| Soleno Therapeutics Inc | Birgitte Volck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 2,666 | 2,666 | - | - | Stock option (right to buy) | |
| Soleno Therapeutics Inc | Birgitte Volck | Director | Grant, award, or other acquisition of securities at price $ 0.36 per share. | 31 Jan 2022 | 35,915 | 105,678 (0%) | 0% | 0.4 | 12,750 | Common Stock |
| Soleno Therapeutics Inc | Birgitte Volck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2021 | 17,141 | 69,763 (0%) | 0% | 0 | Common Stock | |
| Soleno Therapeutics Inc | Birgitte Volck | Director | Grant, award, or other acquisition of securities at price $ 0.91 per share. | 30 Jul 2021 | 14,010 | 52,622 (0%) | 0% | 0.9 | 12,749 | Common Stock |